Piper Sandler raised the firm’s price target on Delek US (DK) to $47 from $39 and keeps a Neutral rating on the shares. The firm notes Q3 results have wrapped and margins remain impressively strong. And while Q3 results were solid, Piper sees Q4 shaping up even better, with capture tailwinds, demand resilient, and margins robust, despite throughput guides suggesting 2.4% increase year-over-year. In the end, the market is clearly tighter than anticipated, and the firm still sees it getting incrementally tighter in 2026, and the futures curve now agrees.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $36 from $28 at TD Cowen
- Delek US price target raised to $45 from $37 at Mizuho
- Delek US Holdings: Hold Rating Maintained Amid Improved Earnings and Future Uncertainties
- Delek US price target raised to $40 from $33 at Scotiabank
- Delek US price target raised to $53 from $43 at Wells Fargo
